NASDAQ:NRXP

Nrx Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy NRXP

*Your capital is at risk

$4.05

-0.570 (-12.34%)

At Close: Jun 03, 2026

NRx Pharmaceuticals to Present at 8th Annual Dawson James Conference

06:48am, Thursday, 05'th Oct 2023

RADNOR, Pa. , Oct. 5, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Dr. Jonatha

NRx Pharma (NRXP) to Initiate Clinical Study on NRX-101, Stock Up

10:31am, Tuesday, 03'rd Oct 2023

NRx Pharma (NRXP) receives FDA clearance to begin clinical development for its lead candidate, NRX-101, to treat chronic pain.

NRx Pharmaceuticals to Present at the Sidoti Virtual Small Cap Conference

06:46am, Monday, 18'th Sep 2023

RADNOR, Pa. , Sept. 18, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Stephen W

NRx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

06:47am, Thursday, 07'th Sep 2023

RADNOR, Pa. , Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Stephen W

NRX Pharmaceuticals, Inc. (NRXP) Q2 2023 Earnings Call Transcript

09:58pm, Monday, 14'th Aug 2023

NRX Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Matthew Duffy - Chief Business Officer Steve Willard - CEO & Director Jonathan

NRx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 14, 2023

06:47am, Monday, 07'th Aug 2023

RADNOR, Pa. , Aug. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a late-stage biopharmaceutical company, today announced that it will releas

NRx Pharmaceuticals to Host Corporate and Strategic Update Conference Call on Monday, June 5, 2023

02:20pm, Friday, 02'nd Jun 2023

RADNOR, Pa. , June 2, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced it will host a c

All You Need to Know About NRx Pharmaceuticals, Inc. (NRXP) Rating Upgrade to Buy

01:01pm, Wednesday, 31'st May 2023

NRx Pharmaceuticals, Inc. (NRXP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

NRx Pharmaceuticals, Inc. (NRXP) Q4 2022 Earnings Call Transcript

10:10pm, Thursday, 30'th Mar 2023

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Suzanne Messere - IR Stephen Willard - CEO Seth Van Voorhees - CFO Jonathan Jav

NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023

06:47am, Friday, 17'th Mar 2023

RADNOR, Pa. , March 17, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage CNS biopharmaceutical company, a Delaware Corporation, t

NRx Pharmaceuticals to Present Scientific Update at the 6th Annual Sachs Associates Neuroscience Innovation Forum in Conjunction with the 2023 J.P. Morgan Healthcare Conference

06:47am, Thursday, 05'th Jan 2023

RADNOR, Pa. , Jan. 5, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will be

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by